Acute decline in kidney function in people with acute liver disease or an exacerbation of end-stage liver disease is called hepatorenal syndrome (HCGT). The disease is mainly seen in patients with cirrhosis, ascites, portal hypertension, alcoholic hepatitis, or more rarely, liver tumors, fulminant hepatitis due to different causes.

The main treatment methods for hepatorenal syndrome are the use of vasopressors, albumin and some invasive techniques, the aim is to prolong the patient's life time.